P H de Mulder

1.0k total citations
18 papers, 754 citations indexed

About

P H de Mulder is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, P H de Mulder has authored 18 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Immunology and 5 papers in Surgery. Recurrent topics in P H de Mulder's work include Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (5 papers) and Renal cell carcinoma treatment (3 papers). P H de Mulder is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (5 papers) and Renal cell carcinoma treatment (3 papers). P H de Mulder collaborates with scholars based in Netherlands, France and Switzerland. P H de Mulder's co-authors include Graham M. Mead, Sophie D. Fosså, Ronald de Wit, Gosse J. Adema, Pat Cook, R. J. Sylvester, M.H. Cullen, A. Horwich, Stan B. Kaye and D.Th. Sleijfer and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.

In The Last Decade

P H de Mulder

18 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P H de Mulder Netherlands 13 322 272 220 201 145 18 754
Katarína Macháleková Slovakia 15 264 0.8× 283 1.0× 88 0.4× 187 0.9× 174 1.2× 47 684
J. L. Pico France 14 211 0.7× 282 1.0× 148 0.7× 231 1.1× 107 0.7× 23 894
Jens Krugmann Austria 18 402 1.2× 101 0.4× 142 0.6× 156 0.8× 99 0.7× 41 857
Martin D. Phillips United States 12 349 1.1× 150 0.6× 144 0.7× 153 0.8× 275 1.9× 16 978
T. Geldart United Kingdom 15 293 0.9× 211 0.8× 122 0.6× 202 1.0× 178 1.2× 40 642
Hs Koops Netherlands 14 284 0.9× 219 0.8× 54 0.2× 169 0.8× 312 2.2× 24 737
Roopinder Gillmore United Kingdom 15 684 2.1× 322 1.2× 210 1.0× 176 0.9× 233 1.6× 49 1.3k
Jeanette Philips Australia 15 218 0.7× 312 1.1× 106 0.5× 213 1.1× 95 0.7× 23 829
Sanghui Park South Korea 18 261 0.8× 228 0.8× 122 0.6× 192 1.0× 133 0.9× 61 801
Gitie Jaffe United States 12 252 0.8× 152 0.6× 234 1.1× 274 1.4× 214 1.5× 13 782

Countries citing papers authored by P H de Mulder

Since Specialization
Citations

This map shows the geographic impact of P H de Mulder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P H de Mulder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P H de Mulder more than expected).

Fields of papers citing papers by P H de Mulder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P H de Mulder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P H de Mulder. The network helps show where P H de Mulder may publish in the future.

Co-authorship network of co-authors of P H de Mulder

This figure shows the co-authorship network connecting the top 25 collaborators of P H de Mulder. A scholar is included among the top collaborators of P H de Mulder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P H de Mulder. P H de Mulder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Voort, Robbert van der, et al.. (2008). Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysis. Cancer Immunology Immunotherapy. 58(3). 429–439. 15 indexed citations
2.
Srinivas, Sandhya, Jan Roigas, Silke Gillessen, et al.. (2007). Continuous daily administration of sunitinib in patients (pts) with cytokine-refractory metastatic renal cell carcinoma (mRCC): Updated results. Journal of Clinical Oncology. 25(18_suppl). 5040–5040. 25 indexed citations
3.
Escudier, Bernard, S. Srinivas, Jan Roigas, et al.. (2007). 4504 ORAL A phase II study of continuous daily administration of sunitinib in patients with cytokine-refractory metastatic renal cell carcinoma (mRCC) – final results. European Journal of Cancer Supplements. 5(4). 299–300. 5 indexed citations
4.
Mulder, P H de, Jan Roigas, Silke Gillessen, et al.. (2006). A phase II study of sunitinib administered in a continuous daily regimen in patients with cytokine-refractory metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology. 24(18_suppl). 4529–4529. 31 indexed citations
5.
Herpen, Carla M. van, Maaike W.G. Looman, Marijke I. Zonneveld, et al.. (2004). Intratumoral Administration of Recombinant Human Interleukin 12 in Head and Neck Squamous Cell Carcinoma Patients Elicits a T-Helper 1 Profile in the Locoregional Lymph Nodes. Clinical Cancer Research. 10(8). 2626–2635. 69 indexed citations
6.
Herpen, Carla M. van, Richard Huijbens, Maaike W.G. Looman, et al.. (2003). Pharmacokinetics and immunological aspects of a phase Ib study with intratumoral administration of recombinant human interleukin-12 in patients with head and neck squamous cell carcinoma: a decrease of T-bet in peripheral blood mononuclear cells.. PubMed. 9(8). 2950–6. 43 indexed citations
7.
Oosterwijk‐Wakka, Jeannette, Dorien M. Tiemessen, Ivar Bleumer, et al.. (2002). Vaccination of Patients With Metastatic Renal Cell Carcinoma With Autologous Dendritic Cells Pulsed With Autologous Tumor Antigens in Combination With Interleukin-2: A Phase 1 Study. Journal of Immunotherapy. 25(6). 500–508. 76 indexed citations
8.
Mulder, P H de. (1999). The chemotherapy of head and neck cancer. Anti-Cancer Drugs. 10. S33–S38. 12 indexed citations
9.
10.
11.
Mulder, P H de. (1996). [Cancer, what is it?].. PubMed. 103(9). 338–40. 4 indexed citations
12.
Mattijssen, Vera, P H de Mulder, Alexander de Graeff, et al.. (1994). Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinoma. Annals of Oncology. 5(10). 957–960. 19 indexed citations
13.
14.
15.
Mattijssen, Vera, et al.. (1992). Human Leukocyte Antigen Expression in Renal Cell Carcinoma Lesions Does Not Predict the Response to Interferon Therapy. Journal of Immunotherapy. 12(1). 64–69. 11 indexed citations
16.
Mulder, P H de. (1992). Measurement of success: parameters of efficacy.. PubMed. 19. S68–S68. 2 indexed citations
17.
Mattijssen, Vera, P H de Mulder, Jan H. Schornagel, et al.. (1991). Clinical and Immunopathological Results of a Phase II Study of Perilymphatically Injected Recombinant Interleukin-2 in Locally Far Advanced, Nonpretreated Head and Neck Squamous Cell Carcinoma. Journal of Immunotherapy. 10(1). 63–68. 37 indexed citations
18.
Klaveren, R.J. van, P H de Mulder, A M Boerbooms, et al.. (1990). Pancreatic carcinoma with polyarthritis, fat necrosis, and high serum lipase and trypsin activity.. Gut. 31(8). 953–955. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarína Macháleková Breakdown of academic impact, for papers by J. L. Pico Breakdown of academic impact, for papers by Jens Krugmann Breakdown of academic impact, for papers by Martin D. Phillips Breakdown of academic impact, for papers by T. Geldart Breakdown of academic impact, for papers by Hs Koops Breakdown of academic impact, for papers by Roopinder Gillmore Breakdown of academic impact, for papers by Jeanette Philips Breakdown of academic impact, for papers by Sanghui Park Breakdown of academic impact, for papers by Gitie Jaffe
Rankless by CCL
2026